ADA Deficiency: Evaluation of the Clinical and Laboratory Features and the Outcome.
Cagdas D, Gur Cetinkaya P, Karaatmaca B, Esenboga S, Tan C, Yılmaz T, Gümüş E, Barış S, Kuşkonmaz B, Ozgur TT, Bali P, Santisteban I, Orhan D, Yüce A, Cetinkaya D, Boztug K, Hershfield M, Sanal O, Tezcan İ.
Cagdas D, et al.
J Clin Immunol. 2018 May;38(4):484-493. doi: 10.1007/s10875-018-0496-9. Epub 2018 May 9.
J Clin Immunol. 2018.
PMID: 29744787
METHODS: Measurement of ADA enzyme activity and metabolites and sequencing of the ADA gene were performed in most of the patients with ADA deficiency. ...Eight patients with ADA-SCID were found to have higher levels of ADA metabolite (dAXP%) (62 …
METHODS: Measurement of ADA enzyme activity and metabolites and sequencing of the ADA gene were performed in most of the patie …